We’re Teva, we develop, produce and market affordable generic medicines, as well as innovative and specialty pharmaceuticals and over-the-counter consumer healthcare products, along with supplying active pharmaceutical ingredients to nearly 1,000 customers in over 100 countries.

We’re the UK arm of Teva Pharmaceutical Industries Ltd; that means we're part of one of the top 10 pharmaceutical companies in the world. With over a century of experience in pharmaceuticals, Teva is a big player on the world stage, which brings considerable benefits to us in the UK.

In the UK we've been around for over 80 years, which is longer than the NHS!

We’re a leader in UK healthcare, supplying a wide range of medicines to the UK’s National Health Service, as well as working alongside NHS organisations to improve the management of long term conditions. 

Today we specialise in both generic and branded medicines, improving the lives of patients, whether it is by fighting infections, controlling cholesterol, relieving the symptoms of asthma, or providing lifesaving injectable medicines and pain relief for cancer sufferers. Our medicines are used in hospitals, pharmacies and clinics.

"Teva plays an important role in delivering value to healthcare systems and economies around the world. The scale of production and accessible price of our products help to limit rising healthcare costs and improve patient health outcomes."

 

Leveraging Teva's size and scale   Bringing generic and innovative medicines to patients in the UK 

Our work at Teva makes a difference   Improving health, enabling better days

 

 

Leveraging Teva's size and scale
________________________________________________________________________________________________________________

Globally, Teva is the world's leading generic drug maker, with a range of more than 16,000 products, and a presence in around 60 countries. We estimate that Teva's medicines reach around 200 million people every day.1

Teva's specialty medicines treat conditions affecting the central nervous system, respiratory, oncology and pain.

"At a global level, Teva has one of the broadest medicines pipelines in the industry. That benefits us working to deliver medicines in the UK; it puts us in a strong position to bring generic versions of branded medicines to market on the first day of patent protection ending, at a competitive price."

Generic medicines create affordable alternatives to treat hundreds of medical conditions, allowing healthcare systems to better manage budgets, while offering more therapies, coverage, and comprehensive care to patients.

Generic medicines are typically sold at a substantially lower price to their branded medicine counterparts, as the development process is generally less costly.

"Generic medicines bring significant savings to the NHS medicines bill – estimates are that generic medicines save the NHS around £13 billion every year, compared to the cost if their branded equivalents had been dispensed.2 This frees up valuable NHS resources to be directed to where patients need it."

We have a strong pipeline of innovative medicines at various developmental stages and we are actively investigating novel uses for existing treatments.

Across our specialty medicines portfolio, Teva focuses on developing, personalising and improving treatment of disorders for patients in CNS, respiratory, oncology, and select local/regional therapeutic areas.

Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies.

Learn more about how we make and supply our medicines >

 

Bringing generic and innovative medicines to patients in the UK
________________________________________________________________________________________________________________

Bringing generic and innovative medicines to patients

We're constantly developing new medicines that patients need – adding to our medicines range with generic and branded therapies.

As well as providing hundreds of generic medicines which are supplied to the country’s thousands of pharmacies and dispensaries, we also supply medicines to treat multiple sclerosis, cancer, pain and respiratory conditions like asthma, Cystic Fibrosis and chronic obstructive pulmonary disease (COPD).

We work hard to make a difference beyond simply supplying medicines to the NHS. We are involved in several partnerships with NHS organizations to provide support to patients and support the NHS mission to improve and modernize services while delivering cost efficiencies.

Our ongoing strong relationship with NHS England led us to become a key partner in the NHS Health and Care Innovation Expo in Manchester. As the sponsor of the “Digital Health Zone,” we helped bring together a range of distinguished thought leaders in digital and mobile health, as well as our own experts, to share information with 5,000 delegates on innovation and opportunities in digital health.

Learn more about our work with the NHS >  

Generic medicines

It takes between eight and 10 years to launch a generic medicine. The early years are spent investigating patents and working on the formulation. As the timeline counts down, the activities focus around gaining the licence, designing the packaging and working with our supply chain to ensure the medicine becomes available for patients as soon as the patent protection has expired.

Learn more about generic medicines > 

Innovative medicines

It can take 10-15 years to develop an innovative medicine. These medicines show distinct advantages, or enhanced new benefits for patients, to already existing therapies. Consequently, costs of development consistently rise and development time is continually increasing.

Learn more about Teva's specialty medicines > 

 

Our work at Teva makes a difference
________________________________________________________________________________________________________________

Our work at Teva makes a difference

We create medicines and services that enable people to better manage their health and focus on living their life so they can do the simple things that matter to them.

We have a new way of looking at people: through health, not only through sickness. This means we will not only help sick people get better – which is what we have done so far – but also help healthy people stay healthy. We will go further “beyond the pill” into integrated solutions, disease management, prevention and overall wellness.

As people seek to play a bigger role in their health, we too must play a bigger role in enabling them to feel more in control by providing both emotional and functional support in the form of the medicines, tools and information they need. 

Real patient insights

Everything we do is based on real patient insights and grounded in real data. We have been listening to our patients in new ways, getting to know them and understand their needs, concerns and aspirations. Our research shows that people want to take better control of their own health and wellness, in ways that have not been possible until now. 

With our strong global footprint, size and scale, and our world-class portfolio of generic and specialty medicines; we are in a unique position to deliver best-in-class, sustainable and accessible solutions that help patients manage their overall health. 

 

 

Improving health, enabling better days
________________________________________________________________________________________________________________

Improving health, enabling better days


We strive to help solve the health challenges of a changing world, putting patients at the center of our work.

This means fully understanding the care they need now and anticipating their needs in the future. It requires developing solutions that transform care - and helping to ensure those solutions are within reach. It involves forming partnerships to help us have an even greater impact.

The result of these efforts will drive better health. Being healthier gives people options, control of their lives, time with loved ones, and achieves our ultimate goal of enabling patients to live better days.


________________________________________________________________________________________________________________

References

[1] Data on file - Teva 

[2] British Generics Manufacturers Association http://www.britishgenerics.co.uk/ accessed on 21.04.18